Jill Oliver
Psychiatric/Mental Health · Carmel, INNPI 1942468863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $903, 5.4 times the $166 reported in 2021.
Across 108 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$496
- Axsome Therapeutics, Inc.$438
- Alkermes, Inc.$360
- Corium, LLC$347
- Vanda Pharmaceuticals Inc.$326
- AbbVie$190
- plus $648 from 12 others
What the payments were for
- Food & beverage$2,806100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $496 |
| Axsome Therapeutics, Inc. | 11 | $438 |
| Alkermes, Inc. | 17 | $360 |
| Corium, LLC | 14 | $347 |
| Vanda Pharmaceuticals Inc. | 14 | $326 |
| AbbVie | 9 | $190 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $155 |
| Tris Pharma Inc | 1 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $59 |
| Bausch Health US, LLC | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Noven Therapeutics, LLC | 2 | $36 |
| Lundbeck LLC | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $24 |
| Neos Therapeutics, LP | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,806 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 28 | $235 |
| Duloxetine Hcl | 12 | $210 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $187 |
| Gabapentin | 20 | $180 |
| Sertraline Hcl | 17 | $89 |
| Mirtazapine | 13 | $83 |
| Quetiapine Fumarate | 13 | $68 |
| Trazodone Hcl | 18 | $54 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Carmel
- Katherine FonteCarmel$8K
- Kirsten HammersleyCarmel$5K
- Amy DoyonCarmel$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.